Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data

BACKGROUND/AIM: Up to 30% of all patients will present with an advanced or a metastatic stage (mUCC) at the moment of the initial diagnosis of urothelial cell carcinoma of the bladder (UCC). We investigated the numbers, the efficacy and toxicity of different chemotherapies for mUCC in daily practice...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Christine, Hofmann, Rainer, Hegele, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334140/
https://www.ncbi.nlm.nih.gov/pubmed/32636673
http://dx.doi.org/10.2147/CMAR.S231508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334140/
https://www.ncbi.nlm.nih.gov/pubmed/32636673
http://dx.doi.org/10.2147/CMAR.S231508

Ejemplares similares